SOPHiA DDM™ Community Pharmacogenomics Solution

Pharmacogenomics solution for NGS analysis that combines a capture enrichment kit with the analytical capabilities of the SOPHiA DDM™ platform. It is designed to evaluate and report genomic variants associated with pharmacogenomics in an accelerated manner.

Detailed description

Operating principle

The solution integrates a capture enrichment kit with the bioinformatics analysis of the SOPHiA DDM™ platform. The panel covers coding and some non-coding regions of 41 genes and 1 pseudogene associated with pharmacogenomics.

The probe design is highly optimized to ensure a high percentage of on-target reads and uniformity of coverage, even in GC-rich regions, including the first exon.

Pharmacogenomics solution

Clinical applications

Product intended for pharmacogenomic analysis using NGS, allowing the identification and characterization of genetic variants associated with drug response.

It facilitates the evaluation of relevant genomic information to support the interpretation of interindividual variability in pharmacological response, through the characterization of genes of pharmacogenomic interest and the determination of genotypes and star alleles.

Benefits

Integrated workflow, from target region enrichment to bioinformatics analysis. Simplifies the detection, annotation and evaluation of pharmacogenomic variants. Facilitates interpretation through specific filtering and annotation tools. Generates pharmacogenomics-specific results and output files, including genotypic information for the genes analyzed. Specialized analysis of complex genes such as CYP2D6. Reduces the time required for the analysis and interpretation of results. Secure and unlimited data storage. Access to the SOPHiA GENETICS community, promoting the exchange of knowledge about variants.

Intended audience/user

Intended for molecular genetics, pharmacogenomics and genomic diagnostics laboratories, as well as professionals specializing in the analysis and interpretation of genetic variants related to drug response.

Considerations
Required starting material: 50 ng of DNA Starting sample type: DNA extracted from peripheral blood

Key aspects

Integrated solution for capture enrichment and bioinformatics analysis for pharmacogenomics.
Coverage of 41 genes and 1 pseudogene of pharmacogenomic interest.
Detection of SNVs, indels, CNVs and star alleles.
Specialized module for CYP2D6, including analysis of CNVs, promoter regions/UTRs and determination of star alleles.
Specific annotation and filtering tools to streamline variant interpretation.
Generation of a pharmacogenomic report with the genotypic status of the genes included in the panel.
High analytical performance in terms of sensitivity, precision and specificity.
Secure data storage.
Integration with the SOPHiA GENETICS community to facilitate the exchange of knowledge about variants.

Presentation details

Product code: CS2532ILLRGLY10

Area:

Molecular Genetics, Pharmacogenomics, Targeted study of specific pathologies
Consult our experts

Google reCaptcha: Invalid site key.

Related products

Duplicα RealTime ApoE Genotyping Kit

In vitro diagnostic kit based on real-time PCR for the qualitative detection of the ApoE*E2, ApoE*E3 and ApoE*E4 alleles in human genomic DNA. Detailed Description Operating principle The kit is based on the specific amplification of target sequences by Real-Time PCR, using specific fluorescent probes. Allelic discrimination is performed using labelled probes: FAM (6-carboxyfluorescein) to…
Clonit
Real Time PCR (qPCR)

Twist Custom Panels for NGS Applications

Twist custom panels are highly customisable solutions, allowing the exact selection of regions, genes, pathways or variants of interest. They are designed to offer high performance, flexibility and precision in all types of applications and starting samples. Detailed Description Operating principle: In practice, the use of custom panels makes it possible to overcome the limitations…
SOPHIA Genetics
Next Generation Sequencing (NGS)

Franklin by QIAGEN for Somatic Analysis

Advanced cloud-based bioinformatics platform designed for the automated analysis, interpretation, and classification of somatic variants in oncology. Through an integrated environment, the system evaluates clinical evidence in real time, automates classification in accordance with AMP/ASCO/CAP guidelines, and provides access to currently active clinical trials. Detailed description Operating principle End-to-end cloud-based solution for the clinical interpretation…
Qiagen
Next Generation Sequencing (NGS)

SeqOne Genomics – Somatic

SeqOne is a bioinformatics platform for NGS data analysis in precision oncology, designed to detect, prioritise and interpret somatic variants and generate actionable clinical reports from raw sequencing data. It helps laboratories and healthcare professionals accelerate the interpretation of NGS data through an end-to-end workflow. Detailed description Operating principle SeqOne Genomics is a genomic data…
SeqOne
Next Generation Sequencing (NGS)